help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 56, No. 5 1032-1034
doi:10.1210/jcem-56-5-1032
Copyright © 1983 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Uberti, E. C. D.
Right arrow Articles by Pansini, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Uberti, E. C. D.
Right arrow Articles by Pansini, R.

Prolactin-Releasing Activity of Dermorphin, a New Synthetic Potent Opiate-Like Peptide, in Normal Human Subjects*

Ettore C. Degli Uberti, Giorgio Trasforini, Severo Salvadori, Roberto Tomatis, Angelo Margutti, Michele Bianconi, Carmela Rotola and Rafffaele Pansini

Institute of Clinical Medicine, and Institute of Pharmaceutical Chemistry, University of Ferrara, 44100 Ferrara, Italy

Address correspondence and requests for reprints to: Dr. Ettore C. degli Uberti, Institute of Clinical Medicine, University of Ferrara, I-44100 Ferrara, Italy.

Dermorphins (D) are heptapeptides (H-Tyr-DAla-Phe-Gly-Tyr-X-Ser-NH2; X, Pro or Hyp) with powerful central and peripheral opiate-like activity, originally isolated from the skin of South American frogs. To study the effect of a synthetic D on PRL secretion in man, either D (5.5 µg/kg · min for 30 min) or D-placebo (0.9% saline) infusion over 30 min was administered iv in random sequence to 11 volunteers (6 women and 5 men). In all the subjects, D induced a significant increase in the levels of PRL, more consistently in women than in men. To investigate whether the increase in PRL was due to the opiate agonist properties of D, the study was repeated in the same subjects during naloxone infusion. The PRL response to D was completely suppressed, suggesting that the peptide exerts its effect on PRL release via an opiate receptor stimulation of the µ-type. These data allow us to conclude that D may affect PRL release in humans; however, further investigation is necessary before any physiological significance might be attributed to D in man. (J Clin Endocrinol Metab 56: 1032, 1983)

* This work was presented in part at the 19th National Congress of the Italian Society of Endocrinology, Genova, Italy, May 11–14,1982.

Received August 3, 1982.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1983 by The Endocrine Society